September 2024

Peer Reviewed Feature Articles
Respiratory infections

Respiratory syncytial virus infection: what’s available to prevent it and what’s coming?

Luke Spence, Mark R. Armstrong, Paul M. Griffin

Respiratory syncytial virus infection prevention is advancing with long-acting monoclonal antibodies and new vaccines approved for older adults and pregnant women. Targeted public health initiatives, standardised national policies and community engagement will be key to ensure these preventives reach all populations.

Sleep and breathing disorders

Parasomnias and insomnia in childhood: assessment and management

Kasey Fullwood, Jasneek Chawla, Natalie Pride, Moya Vandeleur, Karen Waters

Sleep disturbances can have profound impacts on emotional regulation and daytime functioning in children. Behavioural interventions are effective in the treatment of both parasomnias and insomnias and should be regarded as first-line treatment. Pharmaceutical options are available, but these should be prescribed for use concurrently with behavioural interventions.

Genetic and rare lung diseases

Cystic fibrosis management: successes and challenges

Peter A.B. Wark

Outcomes for people living with cystic fibrosis have dramatically improved, particularly with the development of small molecule cystic fibrosis transmembrane conductance regulator modulators, which specifically target the disease process. Despite the advances in treatment, challenges remain for people with this disease and those who care for them.

Peer Reviewed Regular Series
Perspectives

Silicosis in Australia: recent developments and future challenges

Dunya Tomic, Ryan F. Hoy

A ban on artificial stone benchtops in Australia is an important step in protecting workers, but people who have previously worked in this industry, along with others who remain exposed to occupational silica dust, are still at risk.

Briefings